Intravenous administration of the food-derived opioid peptide Gluten Exorphin B5 stimulates prolactin secretion in rats
- 7 January 2003
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 47 (1) , 53-58
- https://doi.org/10.1016/s1043-6618(02)00267-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Behavioral and Pharmacological Studies on Gluten Exorphin A5, a Newly Isolated Bioactive Food Protein Fragment, in MiceThe Japanese Journal of Pharmacology, 2000
- Degradation Kinetics of Leucine5-Enkephalin by Plasma Samples from Healthy Controls and Various Patient PopulationsClinical Journal of Sport Medicine, 2000
- Pharmacokinetics of intravenous dynorphin A(1–13) in opioid-naive and opioid-treated human volunteers*Clinical Pharmacology & Therapeutics, 1998
- Effect of gluten exorphins a5 and b5 on the postprandial plasma insulin level in conscious ratsLife Sciences, 1995
- Gluten exorphin CFEBS Letters, 1993
- Opioid peptides derived from wheat gluten: Their isolation and characterizationFEBS Letters, 1992
- Passage of Undegraded Dietary Antigen into the Blood of Healthy Adults Further Characterization of the Kinetics of Uptake and the Size Distribution of the AntigenScandinavian Journal of Immunology, 1986
- Passage of Undegraded Dietary Antigen into the Blood of Healthy AdultsScandinavian Journal of Immunology, 1985
- Comparative structure-function studies with analogs of dynorphin-(1–13) and [Leu5] enkephalinLife Sciences, 1982
- Leu-enkephalin-stimulated growth hormone and prolactin release in the rat: comparison with the effect of morphineLife Sciences, 1977